Вакцина против COVID-19 Johnson and Johnson

Литература:

Vaccines based on replication incompetent Ad26 viral vectors : standardized template with key considerations for a risk/benefit assessment / J. Custers, D. Kim, M. Leyssen [et al.] // Vaccine. – 2021. – Vol. 39, № 22. – P. 3081–3101.

Интернет-ресурсы:

The Janssen Ad26.COV2.S COVID-19 vaccine: What you need to know // world Health Organisation. – Дата обновления: 6 июня 2022.

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process // World Health Organisation. – Дата публикации: 12 января 2023.

50 Vaccines approved by at least one country // COVID19 Vaccine Tracker. – Дата обновления: 3 мая 2023.

Johnson & Johnson’s Janssen COVID-19 Vaccine: authorized for emergency use // Janssen Global Services.